Sun Pharmaceutical Industries Share Price Today - Live Blog for November 17, 2025

The stock price of Sun Pharmaceutical Industries Ltd enjoyed a significant 0.22% boost, with the current market value at ₹1,765.80 per share. This surge has not gone unnoticed by investors.

The share price of Sun Pharmaceutical Industries Ltd recently experienced a positive upturn, resulting in a 0.11% increase. Presently, it is actively trading at ₹1,765.80.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.05% increase and currently trading at ₹1,764.25 per share. Investors are taking notice of this upward momentum.

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.12%, with its current market value per share resting at ₹1,763.80. This development highlights the stock's appeal to investors.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.06% in its share price, and it currently trades at ₹1,761.75 per share. The stock has an ROE of 14.8407% and debt to equity ratio of 0.0670.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.04%, signalling a challenging period. Currently trading at ₹1,763.35, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Investors are buzzing as Sun Pharmaceutical Industries Ltd's share price soared by an impressive 0.14%. At this moment, it's actively trading at ₹1,764.00, presenting an enticing opportunity for those in the market.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.07% uptick, and they are currently valued at ₹1,761.50, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0670 and an ROE of 14.8407%.

Sun Pharmaceutical Industries Ltd witnessed a -0.03% drop in its share price and is currently trading at ₹1,761.05. With the stock's PE at 40.1900 and the industry PE at 33.4307, investors are weighing their options.

With a -0.03% decrease, Sun Pharmaceutical Industries Ltd's share price is currently at ₹1,761.05. This development raises questions about the factors behind the decline. The stock's PE ratio is 40.1900, while the industry PE is 33.4307.

Sun Pharmaceutical Industries Ltd experienced a -0.03% downturn in its share price, and it's currently trading at ₹1,761.05. This situation is generating interest among value investors who are evaluating the stock's potential.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.10%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,759.60, but investors are assessing whether this is a temporary dip or a long-term trend.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.00%, and as of now, it's trading at ₹1,760.50 per share. This upward trajectory is attracting keen interest from investors.

The share price of Sun Pharmaceutical Industries Ltd experienced an uptrend, surging by 0.08% recently. As of now, this stock is actively trading at a current market price of ₹1,759.65 per share, attracting attention from investors.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.05%, reaching a current market price of ₹1,756.55. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.01% decline, and it currently trades at ₹1,757.60 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.21%, reaching the current market price of ₹1,756.80. This ascent signifies increased investor sentiment. The stock has an ROE of 14.8407% and debt to equity ratio of 0.0670.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.17% gain, with the share price now at ₹1,754.40. Notably, the stock's PE ratio stands at 40.1900, and its Return on Equity (ROE) is 14.8407%.

Sun Pharmaceutical Industries Ltd experienced a substantial 0.19% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,752.25, making it an appealing option for investors.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.19% surge in its share price and is presently trading at ₹1,752.25, captivating the attention of market participants.

With a remarkable 0.08% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,749.00. Notably, this stock has a Price-to-Earnings (PE) ratio of 40.1900, while the industry's PE ratio is 33.4307.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.05%, a development that warrants careful analysis. Presently trading at ₹1,747.60, investors are assessing whether this presents an opportunity or a risk.

The share price of Sun Pharmaceutical Industries Ltd experienced an uptrend, surging by 0.10% recently. As of now, this stock is actively trading at a current market price of ₹1,753.40 per share, attracting attention from investors.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.10% uptick, and they are currently valued at ₹1,753.40, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0670 and an ROE of 14.8407%.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.56% slump and is currently trading at ₹1,749.90. While the stock maintains a PE ratio of 40.1900, the industry PE is 33.4307, raising questions about valuation.

Sun Pharmaceutical Industries Ltd observed a -0.22% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,760.20. The stock has a PE ratio of 40.1900, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd's share price rallied by 0.34%, reaching the current market price of ₹1,764.00. This surge is indicative of the stock's recent positive performance.

After a -0.74% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,756.85. The stock has a PE ratio of 40.1900, an ROE of 14.8407% and a debt to equity ratio of 0.0670.